Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2005-03-15
2005-03-15
Salimi, Ali R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S130100, C435S345000, C435S007100, C530S300000
Reexamination Certificate
active
06866854
ABSTRACT:
This invention provides an isolated nucleic acid which encodes a Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 2 polypeptide (LANA2) or a fragment thereof and also provides the LANA2 polypeptide. This invention provides an isolated nucleic acid comprising consecutive nucleotides having the sequence of a promoter of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 2 transcription. This invention also provides a method of inhibiting p53 mediated apoptosis of a cell and a method of producing an antibody which comprises introducing into a cell a replicable vector of the subject invention.
REFERENCES:
patent: 5801042 (1998-09-01), Chang et al.
patent: 5830759 (1998-11-01), Chang et al.
patent: 6150093 (2000-11-01), Chang et al.
patent: 6319667 (2001-11-01), Haas et al.
patent: WO 9606159 (1996-02-01), None
patent: WO 9727208 (1997-07-01), None
patent: WO 9804576 (1998-02-01), None
Pierrotti et al, Journal of Clinical Virology, May 2000, vol. 16, pp. 247-251.*
Kellam et al, Journal of Virology, Jun. 1999, vol. 73, No. 6, pp. 5194-5155.*
Zhu et al, Virology, Apr. 1999, vol. 256, pp. 381-392.*
Rainbow et al, Journal of Virology, Aug. 1997, vol. 71, No. 8, pp. 5915-5921.*
Alexander, L., et al. (2000) “The Primary Sequence of Rhesus Monkey Rhadinovirus Isolate 26-95: Sequence Similarities To Kaposi's Sarcoma-Associated Herpesvirus And Rhesus Monkey Rhadinovirus Isolate” 17577.J. Virol.74:3388-98.
Bais, C., et al. (1998) “G-Protein-Coupled Receptor Of Kaposi's Sarcoma-Associated Herpesvirus Is A Viral Oncogene And Angiogenesis Activator”Nature391:86-9.
Ballestas, M.E., et al. (1999) “Efficient Persistence Of Extrachromosomal KSHV DNA Mediated By Latency-Associated Nuclear Antigen”Science284:641-4.
Burysck, L., et al. (1999) “Functional Analysis Of Human Herpesvirus 8-Encoded Viral Interferon Regulatory Factor 1 And Its Association With Cellular Interferon Regulatory Factors And p300”J. Virol.73:7334-42.
Burysek, L., et al. (1999) “Unique Properties Of A Second Human Herpesvirus 8-Encoded Interferon Regulatory Factor (vIRF-2)”J. Hum. Virol.2:19-21.
Cesarman, E., et al. (1995) “Kaposi's Sarcoma-Associated Herpesvirus-Like DNA Sequences In AIDS-Related-Body-Cavity-Based Lymphomas”New. Eng. J. Med.332:1186-1191.
Chang, Y., et al. (1996) “Cyclin Encoded By KS Herpesvirus”Nature382:410.
Chang, Y., et al. (1994) “Identification Of Herpes-Like DNA Sequences In AIDS-Associated Kaposi's Sarcoma”,Science265:1865-1869.
Davis, M.A., et al. (1997) “Expression Of Human Herpesvirus 8-Encoded Cyclin D In Kaposi's Sarcoma Spindle Cells”J. Natl. Cancer Inst.89:1868-74.
Dittmer, D., et al. (1998) “A Cluster Of Latently Expressed Genes In Kaposi's Sarcoma-Associated Herpesvirus”J. Virol.72:8309-15.
Dupin, N., et al. (1999) “Distribution Of Human Herpesvirus-8 Latently Infected Cells In Kaposi's Sarcoma, Multicentric Castleman's Disease, And Primary Effusion Lymphoma”Proc. Natl. Acad. Sci. U.S.A.96:4546-51.
Flowers, C., et al. (1998) “Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor Confers Resistance To The Antiproliferative Effect Of Interferon-Alpha”Mol. Med.4:402-12.
Friborg, J., et al. (1999) “p53 Inhibition By The LANA Protein Of KSHV Protects Against Cell Death”Nature402:889-94.
Gao, S.-J., et al. (1997) “KSHV ORF K9 (vIRF) Is An Oncogene Which Inhibits The Interferon Signaling Pathway”Oncogene15:1979-85.
Gao, S.J., et al. (1996) “KSHV antibodies among Americans, Italians And Ugandans With And Without Kaposi's Sarcoma”Nature Medicine2:925-8.
Godden-Kent, D., et al. (1997) “The Cyclin Encoded by Kaposi's Sarcoma-Associated Herpesvirus Stimulates cdk6 to Phosphorylate the Tetinoblastoma Protein and Histone H1”J. Virol.71:4193-8.
Gu, W., et al. (1997) “Activation Of p53 Sequence-Specific DNA Binding By Acetylation Of The p53 C-Terminal Domain”Cell90:595-606.
Jayachandra, S., et al. (1999) “Three Unrelated Viral Transforming Proteins (vIRF, EBNA2, and E1A) Induce The MYC Oncogene Through The Interferon-Responsive PRF Element By Using Different Transcription Coadaptors”Proc. Natl. Acad. Sci. U.S.A.96:11566-11571.
Judde, J.G., et al. (2000) “Monoclonality or Oligoclonality of Human Herpesvirus 8 Terminal Repeat Sequences in Kaposi's Sarcoma And Other Diseases”J. Natl. Cancer Inst.92:729-736B.
Katano, H., et al. (2000) “Expression And Localization Of Human Herpesvirus 8-Encoded Proteins In Primary Effusion Lumphoma, Kaposi's Sarcoma, And Multicentric Castleman's Disease”Virology269:335-44.
Katano, H., et al. (1999) “High Expression Of HHV-8-Encoded ORF73 Protein In Spindle-Shaped Cells Of Kaposi's Sarcoma”Am. J. Pathol.155:47-52.
Kirshner, J.R., et al. (1999) “Expression Of The Open Reading Frame 74 (G-Protein-Coupled Receptor) Gene Of Kaposi's Sarcoma (KS)-Associated Herpesvirus: Implications For KS Pathogenesis”J. Virol.73:6006-14.
Lee, H., et al. (1998) “Deregulation Of Cell Growth By The K1 Gene Of Kaposi's Sarcoma-Associated Herpesvirus”Nat. Med.4:435-40.
Li, M., et al. (1998) “Kaposi's Sarcoma-Associated Herpesvirus viral Interferon Regulatory Factor”J. Virol.72:5433-40.
Li, M., et al. (1997) “Kaposi's Sarcoma-Associated Herpesvirus Encodes A Functional Cyclin”J. Virol.71:1984-91.
Moore, P.S., et al. (1996) “Molecular Mimicry Of Human Cytokine And Cytokine Response Pathway Genes By KSHV”Science274:1739-1744.
Moore, P.S., et al. (1995) “Detection Of Herpesvirus-like DNA Sequences In Kaposi's Sarcoma In Patients With And Those Without HIV infection”New Eng. J. Med.332:1181-1185.
Moore, P.S., et al. (1996) “Primary Characterization Of A Herpesvirus Agent Associated With Kaposi's Sarcoma”J. Virol.70(1):549-558.
Neipel, F., et al. (1997) “Cell-Homologous Genes In The Kaposi's Sarcoma-Associated Rhadinovirus Human Herpesvirus 8: Determinants Of Its Pathogenicity?”J. Virol.71:4187-92.
Ojala, P.M., et al. (1999) “Kaposi's Sarcoma-Associated Herpesvirus-Encoded v-Cyclin Triggers Apoptosis In Cells With High Levels Of Cyclin-Dependent Kinase 6”Cancer Res.59:4984-9.
Parravicini, C., et al. (2000) “Differential Viral Protein Expression In Kaposi's Sarcoma-Associated Herpesvirus-Infected Diseases: Kaposi's Sarcoma, Primary Effusion Lymphoma, And Multicentric Castleman's Disease”Am. J. Pathol.156:743-9.
Reed, J.A., et al. (1998) “Demonstration Of Kaposi's Sarcoma-Associated Herpes Virus Cyclin D Homolog In Cutaneous Kaposi's Sarcoma By Colorimetric In Situ Hybridization Using A Catalyzed Signal Amplification System”Blood91:3825-32.
Russo, J.J., et al. (1996) “Nucleotide Sequence Of The Kaposi Sarcoma-Associated Herpesvirus (HHV8) ”Proc. Natl. Acad. Sci. U.S.A.93:14862-7.
Sarid, R., et al. (1998) “Transcription Mapping Of The Kaposi's Sarcoma-Associated Herpesvirus (human herpesvirus 8) Genome In A Body Cavity-Based Lymphoma Cell Line (BC-1)”J. Virol.72:1005-12.
Sarid, R., et al. (1997) “Kaposi's Sarcoma-Associated Herpesvirus Encodes A Functional bcl-2 Homologue”Nature Medicine3:293-8.
Sarid, R., et al. (1999) “Characterization And Cell Cycle Regulation Of The Major Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Latent Genes And Their Promoter”J. Virol.73:1438-46.
Sun, R. et al. (1999) “Kinetics Of Kaposi's Sarcoma-Associated Herpesvirus Gene Expression”J. Virol.73:2232-42.
Takebe, Y., et al. (1988) “SRα promoter: An Efficient And Versatile Mammalian cDNA Expression System Composed Of The Simian Virus 40 Early Promoter And The R-U5 Segment Of The Human T-Cell Leukemia Virus Type 1 Long Terminal Repeat”Mol. Cell Biol.8:466-72.
Talbot, S.J., et al. (1999) “Transcriptional Analysis Of Human
Chang Yuan
Moore Patrick S.
Cooper & Dunham LLP
Salimi Ali R.
The Trustees of Columbia University in the City of New York
White John P.
LandOfFree
Spliced gene of KSHV/HHV8, its promoter and monoclonal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spliced gene of KSHV/HHV8, its promoter and monoclonal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spliced gene of KSHV/HHV8, its promoter and monoclonal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3400623